Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs ADVANCED ENZYME TECHNOLOGIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAYMED LABS ADVANCED ENZYME TECHNOLOGIES RAYMED LABS/
ADVANCED ENZYME TECHNOLOGIES
 
P/E (TTM) x -7.1 27.9 - View Chart
P/BV x - 3.1 - View Chart
Dividend Yield % 0.0 1.4 -  

Financials

 RAYMED LABS   ADVANCED ENZYME TECHNOLOGIES
EQUITY SHARE DATA
    RAYMED LABS
Mar-23
ADVANCED ENZYME TECHNOLOGIES
Mar-23
RAYMED LABS/
ADVANCED ENZYME TECHNOLOGIES
5-Yr Chart
Click to enlarge
High Rs2328 0.6%   
Low Rs1225 0.7%   
Sales per share (Unadj.) Rs048.3 0.0%  
Earnings per share (Unadj.) Rs-0.49.3 -4.3%  
Cash flow per share (Unadj.) Rs-0.412.4 -3.1%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Avg Dividend yield %01.8 0.0%  
Book value per share (Unadj.) Rs-5.4110.5 -4.9%  
Shares outstanding (eoy) m4.27111.82 3.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x05.7-  
Avg P/E ratio x-4.429.8 -14.8%  
P/CF ratio (eoy) x-4.622.3 -20.5%  
Price / Book Value ratio x-0.32.5 -13.1%  
Dividend payout %053.8 -0.0%   
Avg Mkt Cap Rs m830,939 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m01,148 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m05,406 0.0%  
Other income Rs m0255 0.1%   
Total revenues Rs m05,661 0.0%   
Gross profit Rs m-21,534 -0.1%  
Depreciation Rs m0350 0.0%   
Interest Rs m035 0.0%   
Profit before tax Rs m-21,404 -0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0365 0.0%   
Profit after tax Rs m-21,039 -0.2%  
Gross profit margin %028.4- 
Effective tax rate %026.0 -0.0%   
Net profit margin %019.2- 
BALANCE SHEET DATA
Current assets Rs m07,221 0.0%   
Current liabilities Rs m1776 0.1%   
Net working cap to sales %0119.2- 
Current ratio x0.19.3 0.6%  
Inventory Days Days0255- 
Debtors Days Days068- 
Net fixed assets Rs m26,884 0.0%   
Share capital Rs m43224 19.1%   
"Free" reserves Rs m-6612,127 -0.5%   
Net worth Rs m-2312,351 -0.2%   
Long term debt Rs m078 0.0%   
Total assets Rs m214,105 0.0%  
Interest coverage x041.4-  
Debt to equity ratio x00 -0.0%  
Sales to assets ratio x00.4 0.0%   
Return on assets %-109.57.6 -1,438.6%  
Return on equity %7.48.4 88.1%  
Return on capital %7.411.6 64.0%  
Exports to sales %017.3-  
Imports to sales %07.8-  
Exports (fob) Rs mNA937 0.0%   
Imports (cif) Rs mNA420 0.0%   
Fx inflow Rs m0937 0.0%   
Fx outflow Rs m0420 0.0%   
Net fx Rs m0518 0.0%   
CASH FLOW
From Operations Rs m-21,404 -0.1%  
From Investments Rs m2-2,982 -0.1%  
From Financial Activity Rs mNA-258 -0.0%  
Net Cashflow Rs m0-1,709 0.0%  

Share Holding

Indian Promoters % 28.4 2.6 1,112.2%  
Foreign collaborators % 0.0 41.1 -  
Indian inst/Mut Fund % 1.0 29.5 3.3%  
FIIs % 0.0 22.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.6 56.4 127.1%  
Shareholders   1,498 73,034 2.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAYMED LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RAYMED LABS. vs ADVANCED ENZYME TECHNOLOGIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RAYMED LABS. vs ADVANCED ENZYME TECHNOLOGIES Share Price Performance

Period RAYMED LABS. ADVANCED ENZYME TECHNOLOGIES S&P BSE HEALTHCARE
1-Day 0.00% -1.96% 1.18%
1-Month 3.32% -9.39% -0.75%
1-Year 6.86% 51.81% 61.82%
3-Year CAGR 31.90% -0.39% 18.16%
5-Year CAGR -1.90% 15.53% 19.79%

* Compound Annual Growth Rate

Here are more details on the RAYMED LABS. share price and the ADVANCED ENZYME TECHNOLOGIES share price.

Moving on to shareholding structures...

The promoters of RAYMED LABS. hold a 28.4% stake in the company. In case of ADVANCED ENZYME TECHNOLOGIES the stake stands at 43.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RAYMED LABS. and the shareholding pattern of ADVANCED ENZYME TECHNOLOGIES.

Finally, a word on dividends...

In the most recent financial year, RAYMED LABS. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

ADVANCED ENZYME TECHNOLOGIES paid Rs 5.0, and its dividend payout ratio stood at 53.8%.

You may visit here to review the dividend history of RAYMED LABS., and the dividend history of ADVANCED ENZYME TECHNOLOGIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.